Medicine and Dentistry
Biopsy
33%
Cancer
16%
Cancer of Unknown Primary Origin
29%
Cannula
15%
Chemoradiotherapy
17%
Cohort Analysis
15%
Cylindroma
18%
Diagnosis
45%
Disease
28%
Disease Specific Survival
22%
Epidermal Growth Factor Receptor
15%
Fine-Needle Aspiration
15%
Head and Neck Cancer
98%
Laryngectomy
15%
Lymph Node
20%
Lymph Node Metastasis
18%
Malignant Neoplasm
36%
Metastatic Carcinoma
31%
Microvascular Reconstruction
15%
Mouth Squamous Cell Carcinoma
49%
Neck
98%
Neck Dissection
42%
Neoplasm
64%
Oral Cancer
55%
Oral Cavity
27%
Oropharyngeal Cancer
34%
Oropharynx Squamous Cell Carcinoma
77%
Overall Survival
50%
Pediatric Cancer
15%
Pediatrics
27%
Phase II Trials
15%
Primary Tumor
33%
Prognostic Factor
38%
Quality of Life
23%
Radiation Therapy
58%
Receptor
16%
Recurrence Free Survival
26%
Recurrent Disease
36%
Robot-Assisted Surgery
72%
Salivary Gland Cancer
15%
Salivary Gland Carcinoma
28%
Sentinel Node
47%
Squamous Cell Carcinoma
42%
Surgeon
19%
Surgery
36%
Survival Rate
27%
Thromboplastin
15%
Tracheotomy
31%
Urokinase Receptor
15%
Wart Virus
65%
Keyphrases
5-year Survival
22%
Adenoid Cystic Carcinoma
18%
Age-specific Incidence
19%
Cancer Center
20%
Chemoradiation
15%
Children with Cancer
16%
Cricothyroidotomy
15%
Denmark
82%
Diagnostic Accuracy
18%
Diagnostic Work-up
17%
Disease-specific Survival
22%
Enhanced Recovery after Surgery (ERAS®)
15%
Expression Pattern
15%
Fine-needle Aspiration
15%
Head-and-neck
52%
Head-and-neck Cancer
90%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
19%
High-risk Human Papillomavirus (HR-HPV)
43%
Histology
20%
Incidence Rate
18%
Lymph Node Ratio
15%
Microvascular Reconstruction
15%
Near-infrared Fluorescence Imaging
20%
Neck Dissection
44%
Occult Metastasis
19%
Older Adults
18%
Oral Cancer
41%
Oral Cavity Cancer
15%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
55%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Overall Survival
31%
Pediatric
18%
Phase II Trial
15%
Plasminogen Receptor
15%
Primary Tumor
21%
Prognostic Factors
29%
Radiotherapy
38%
Recurrence-free Survival
24%
Retrospective Longitudinal Study
15%
Salivary Duct Carcinoma
28%
Salivary Gland Cancer
15%
Sentinel Lymph Node
21%
Sentinel Lymph Node Biopsy
27%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
15%
Survival Rate
17%
Tissue Factor
15%
Transoral Robotic Surgery
72%
Transtracheal Cannula
15%
Tumor
25%
Validation Studies
15%